# Novel siRNA Therapeutic Cuts Liver Fat in MASLD, Early Trial Shows

Source: [MedPageToday.com - medical news for physicians](https://www.medpagetoday.com/meetingcoverage/aasld/123822) · 2026-11-10 · Medicine
Page: https://themorning.science/story/novel-sirna-therapeutic-cuts-liver-fat-in-masld-early-trial-shows-7617d07348bd9dca
Kind: research · Impact: medium

## In brief

- A single dose of the siRNA therapy CIDEBsiRNA (also known as ALN-CIDEB) led to normal liver fat content in most patients with MASLD in an early trial.
- In the same patients, the therapy lowered alanine aminotransferase (ALT) levels.
- The results come from an early-stage trial reported at an AASLD meeting, so they are preliminary.

## Why it matters

It is an early sign that silencing the CIDEB gene with siRNA may reduce liver fat in MASLD, a common liver condition with few approved drug treatments. Larger, longer trials are needed before it affects clinical practice.

## Coverage

- [Novel siRNA Therapeutic Cuts Liver Fat in MASLD, Early Trial Shows](https://www.medpagetoday.com/meetingcoverage/aasld/123822) — MedPageToday.com - medical news for physicians, 2026-11-10

Tags: masld, sirna, liver fat, clinical trial, liver disease

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science